Tag: mifepristone

New Poll Shows Strong Support in the U.S. for Medication Abortion

Across party lines, Americans support access to medication abortion and the ability to make abortion decisions.

U.S. Supreme Court to Hear Case That Threatens Access to Abortion Medication

Court agrees to review lower court ruling that attempted to reinstate burdensome restrictions on mifepristone.

Supreme Court Will Hear Case that Could Undermine Abortion Pill Access Nationwide

12.13.23 (PRESS RELEASE) — Today, the U.S. Supreme Court agreed to take up a case that could ultimately eliminate access to mifepristone—one of two drugs used in medication abortion. The case was filed by an anti-abortion group seeking to undo FDA approval of the drug and remove it from the market nationwide. The high court will […]

District Court Ruling in Whole Woman’s Health Alliance v. FDA

On August 21, 2023, a federal court in Virginia denied the Center’s request for a preliminary injunction that would have protected access to the abortion pill mifepristone in Virginia, Montana, and Kansas. In its ruling, the court acknowledged the safety and importance of mifepristone, and the case will proceed in the trial court.  Read more about […]

Court Rules to Reinstate Significant Restrictions on Abortion Medication but Not to Revoke FDA Approval of the Drug

Mifepristone will remain available under current regulations due to an earlier U.S. Supreme Court order.

Appellate Court Rules to Reinstate Restrictions on Abortion Pill 

08.16.23 (PRESS RELEASE) — Today, the U.S. Court of Appeals for the Fifth Circuit largely upheld an unprecedented order from Judge Matthew Kacsmaryk threatening access to mifepristone—one of two drugs used in medication abortion. The federal appellate court ruled for the second time to reinstate burdensome restrictions on mifepristone from pre-2016, but not to revoke FDA […]

Center Files Lawsuit to Ensure Access to Abortion Drug in Three States

Lawsuit seeks to protect mifepristone access in Virginia, Montana, and Kansas in light of the drug’s legal uncertainty.

News and Analysis: Alliance for Hippocratic Medicine v. FDA

Read more about the case here: Alliance for Hippocratic Medicine v. FDA

The Center and Movement Partners Urge Court to Block Unprecedented Ruling Rejecting FDA’s Approval of Abortion Drug

Amicus brief of more than 100 reproductive rights, health, and justice partners highlights the proven safety and efficacy of the drug, the ruling’s “immediate and life-threatening consequences,” and the court’s reliance on “debunked data.”